These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 20053445)

  • 1. Calcium, cellular aging, and selective neuronal vulnerability in Parkinson's disease.
    Surmeier DJ; Guzman JN; Sanchez-Padilla J
    Cell Calcium; 2010 Feb; 47(2):175-82. PubMed ID: 20053445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of calcium and mitochondrial oxidant stress in the loss of substantia nigra pars compacta dopaminergic neurons in Parkinson's disease.
    Surmeier DJ; Guzman JN; Sanchez-Padilla J; Schumacker PT
    Neuroscience; 2011 Dec; 198():221-31. PubMed ID: 21884755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What causes the death of dopaminergic neurons in Parkinson's disease?
    Surmeier DJ; Guzman JN; Sanchez-Padilla J; Goldberg JA
    Prog Brain Res; 2010; 183():59-77. PubMed ID: 20696315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium homeostasis, selective vulnerability and Parkinson's disease.
    Chan CS; Gertler TS; Surmeier DJ
    Trends Neurosci; 2009 May; 32(5):249-56. PubMed ID: 19307031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The origins of oxidant stress in Parkinson's disease and therapeutic strategies.
    Surmeier DJ; Guzman JN; Sanchez-Padilla J; Goldberg JA
    Antioxid Redox Signal; 2011 Apr; 14(7):1289-301. PubMed ID: 20712409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A molecular basis for the increased vulnerability of substantia nigra dopamine neurons in aging and Parkinson's disease.
    Chan CS; Gertler TS; Surmeier DJ
    Mov Disord; 2010; 25 Suppl 1():S63-70. PubMed ID: 20187241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1.
    Guzman JN; Sanchez-Padilla J; Wokosin D; Kondapalli J; Ilijic E; Schumacker PT; Surmeier DJ
    Nature; 2010 Dec; 468(7324):696-700. PubMed ID: 21068725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lower Affinity of Isradipine for L-Type Ca
    Ortner NJ; Bock G; Dougalis A; Kharitonova M; Duda J; Hess S; Tuluc P; Pomberger T; Stefanova N; Pitterl F; Ciossek T; Oberacher H; Draheim HJ; Kloppenburg P; Liss B; Striessnig J
    J Neurosci; 2017 Jul; 37(28):6761-6777. PubMed ID: 28592699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Converging roles of ion channels, calcium, metabolic stress, and activity pattern of Substantia nigra dopaminergic neurons in health and Parkinson's disease.
    Duda J; Pötschke C; Liss B
    J Neurochem; 2016 Oct; 139 Suppl 1(Suppl Suppl 1):156-178. PubMed ID: 26865375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'Rejuvenation' protects neurons in mouse models of Parkinson's disease.
    Chan CS; Guzman JN; Ilijic E; Mercer JN; Rick C; Tkatch T; Meredith GE; Surmeier DJ
    Nature; 2007 Jun; 447(7148):1081-6. PubMed ID: 17558391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium and Parkinson's disease.
    Surmeier DJ; Schumacker PT; Guzman JD; Ilijic E; Yang B; Zampese E
    Biochem Biophys Res Commun; 2017 Feb; 483(4):1013-1019. PubMed ID: 27590583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium, ageing, and neuronal vulnerability in Parkinson's disease.
    Surmeier DJ
    Lancet Neurol; 2007 Oct; 6(10):933-8. PubMed ID: 17884683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parkinson's Disease: Cells Succumbing to Lifelong Dopamine-Related Oxidative Stress and Other Bioenergetic Challenges.
    Watanabe H; Dijkstra JM; Nagatsu T
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium, mitochondrial dysfunction and slowing the progression of Parkinson's disease.
    Surmeier DJ; Halliday GM; Simuni T
    Exp Neurol; 2017 Dec; 298(Pt B):202-209. PubMed ID: 28780195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression analysis of dopaminergic neurons in Parkinson's disease and aging links transcriptional dysregulation of energy metabolism to cell death.
    Elstner M; Morris CM; Heim K; Bender A; Mehta D; Jaros E; Klopstock T; Meitinger T; Turnbull DM; Prokisch H
    Acta Neuropathol; 2011 Jul; 122(1):75-86. PubMed ID: 21541762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age and Parkinson's disease-related neuronal death in the substantia nigra pars compacta.
    Eriksen N; Stark AK; Pakkenberg B
    J Neural Transm Suppl; 2009; (73):203-13. PubMed ID: 20411779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutant α-Synuclein Overexpression Induces Stressless Pacemaking in Vagal Motoneurons at Risk in Parkinson's Disease.
    Lasser-Katz E; Simchovitz A; Chiu WH; Oertel WH; Sharon R; Soreq H; Roeper J; Goldberg JA
    J Neurosci; 2017 Jan; 37(1):47-57. PubMed ID: 28053029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of dopamine oxidation in mitochondrial dysfunction: implications for Parkinson's disease.
    Hastings TG
    J Bioenerg Biomembr; 2009 Dec; 41(6):469-72. PubMed ID: 19967436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurophysiology: stressful pacemaking.
    Bean BP
    Nature; 2007 Jun; 447(7148):1059-60. PubMed ID: 17597746
    [No Abstract]   [Full Text] [Related]  

  • 20. Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease.
    Trist BG; Hare DJ; Double KL
    Aging Cell; 2019 Dec; 18(6):e13031. PubMed ID: 31432604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.